Scientists from Boston University and other institutions have identified a blood biomarker that could help detect the ...

To identify and follow blood ... to mild dementia, we found that plasma levels of this protein, placental growth factor (PlGF), could potentially be used as a biomarker to screen for and monitor ...

The MMSE takes around 10 minutes and is widely used in healthcare settings to screen for dementia. In a 2021 study, Scharre and other researchers compared results from the two tests over an 8-year ...

A trial to identify fast and accurate blood tests that can diagnose dementia comes at an "exciting" time in the treatment of the disease, according to a leading scientist. More than 3,800 people ...

Background Worldwide, the population is ageing, resulting in an associated increase in dementia prevalence. Forgetfulness in elderly people is often perceived as normal in some local cultures and ...

To identify and follow blood vessel-related changes ... to cognitive impairment and dementia (VCID), PlGF could be used as a cost-effective screening tool for identifying patients at risk for ...

New research from Wake Forest University School of Medicine suggests that living in a disadvantaged neighborhood is ...

Doctors at Royal Melbourne Institute of Technology developed a blood test to screen cancer patients and ... researchers found the best way to reduce dementia risk and preserve memory is by ...

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas issue of The BMJ.

It will also develop a system using a blood test that can estimate the overall risk of dementia, including Alzheimer's disease. Alzheimer’s disease is believed to be caused from a buildup in the ...